Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18 (EurekAlert!)

( Indiana University ) Women’s responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month’s Cancer Biology & Therapy.

Original post:
Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18 (EurekAlert!)